Enlivex Ltd. (ENLV)
NCM – Real vaqt narxi. Valyuta: USD
1.90
-0.02 (-1.17%)
Bozor ochiq: Aug 12, 2026, 1:58 PM EDT
1.95
+0.03 (1.56%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
1.90
-0.02 (-1.17%)
Bozor ochiq: Aug 12, 2026, 1:58 PM EDT
1.95
+0.03 (1.56%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Enlivex Ltd. o'z sho'ba korxonalari bilan birgalikda Isroilda makrofag reprogrammasi immunoterapiyasi bo'yicha klinik bosqichda faoliyat yuritadi. U makrofag gomeostazini tiklash uchun mo'ljallangan hujayrali terapiya AllocetraTMni taklif qiladi, shuningdek, 1/2 bosqich sinovlarida bo'lgan tizza osteoartritini davolash uchun AllocetraTM intra-artikulyar in'ektsiyasini; temporomandibular bo'g'im (TMJ) osteoartritida intra-artikulyar AllocetraTMni; va 2-bosqichda bo'lgan kattalar sepsis bemorlarida organ etishmovchiligini davolash uchun Allocetra-OTSni ishlab chiqadi. Enlivex Ltd. ilgari Enlivex Therapeutics Ltd. nomi bilan tanilgan va 2026 yil fevral oyida Enlivex Ltd. nomini o'zgartirgan. Kompaniya 2005 yilda tashkil etilgan va shtab-kvartirasi Isroilning Ness Ziona shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Einat Galamidi M.D. | Chief Medical Officer |
| Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer |
| Dr. Veronique Amor-Baroukh | Chief Operating Officer |
| Mr. Shai Novik M.B.A. | Executive Chairman |
| Ms. Shachar Shlosberger CPA | Chief Financial Officer |
| Ms. Sigal Arad | Director of Human Resources |
| Prof. Dror Mevorach M.D. | Founder & Scientific Advisor |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-11 | 6-K | ea0301590-6k_enlivex.htm |
| 2026-08-06 | F-3 | ea0300828-f3_enlivex.htm |
| 2026-07-30 | 6-K | ea0299702-6k_enlivex.htm |
| 2026-07-29 | 6-K | ea0299617-6k_enlivex.htm |
| 2026-07-28 | 6-K | ea0299538-6k_enlivex.htm |
| 2026-07-20 | 6-K | ea0298496-6k_enlivex.htm |
| 2026-07-13 | 6-K | ea029772501-6k_enlivex.htm |
| 2026-07-07 | 6-K | ea0297195-6k_enlivex.htm |
| 2026-06-24 | 6-K | ea0295702-6k_enlivex.htm |
| 2026-06-22 | 6-K | ea0295405-6k_enlivex.htm |